CFTR and cystic fibrosis: Therefore, in principle, it may be possible to obtain stem lung cells from a CF patient, engineering them with Crispr/Cas9 to correct the CFTR mutation, and reinsert them into one of those lung niches where stem cells find their suitable microenvironment for their survival and growth.